» Articles » PMID: 24972386

Monomeric C-reactive Protein and Notch-3 Co-operatively Increase Angiogenesis Through PI3K Signalling Pathway

Overview
Journal Cytokine
Date 2014 Jun 28
PMID 24972386
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

C-reactive protein (CRP) is the most acute-phase reactant serum protein of inflammation and a strong predictor of cardiovascular disease. Its expression is associated with atherosclerotic plaque instability and the formation of immature micro-vessels. We have previously shown that CRP upregulates endothelial-derived Notch-3, a key receptor involved in vascular development, remodelling and maturation. In this study, we investigated the links between the bioactive monomeric CRP (mCRP) and Notch-3 signalling in angiogenesis. We used in vitro (cell counting, wound-healing and tubulogenesis assays) and in vivo (chorioallantoic membrane) angiogenic assays and Western blotting to study the angiogenic signalling pathways induced by mCRP and Notch-3 activator chimera protein (Notch-3/Fc). Our results showed an additive effect on angiogenesis of mCRP stimulatory effect combined with Notch-3/Fc promoting bovine aortic endothelial cell (BAEC) proliferation, migration, tube formation in Matrigel(TM) with up-regulation of phospho-Akt expression. The pharmacological blockade of PI3K/Akt survival pathway by LY294002 fully inhibited in vitro and in vivo angiogenesis induced by mCRP/Notch-3/Fc combination while blocking Notch signalling by gamma-secretase inhibitor (DAPT) partially inhibited mCRP/Notch-3/Fc-induced angiogenesis. Using a BAEC vascular smooth muscle cell co-culture sprouting angiogenesis assay and transmission electron microscopy, we showed that activation of both mCRP and Notch-3 signalling induced the formation of thicker sprouts which were shown later by Western blotting to be associated with an up-regulation of N-cadherin expression and a down-regulation of VE-cadherin expression. Thus, mCRP combined with Notch-3 activator promote angiogenesis through the PI3K/Akt pathway and their therapeutic combination has potential to promote and stabilize vessel formation whilst reducing the risk of haemorrhage from unstable plaques.

Citing Articles

Advances in the treatment of liver injury based on mesenchymal stem cell-derived exosomes.

Hu C, Wang L Stem Cell Res Ther. 2024; 15(1):474.

PMID: 39696473 PMC: 11657567. DOI: 10.1186/s13287-024-04087-3.


Severe COVID-19 in HIV/Leishmania infantum coinfected patient: a successfully managed case report.

Farias P, Bezerra G, Neves P, Cabral L, Junior W, Guedes D BMC Infect Dis. 2024; 24(1):854.

PMID: 39174900 PMC: 11342618. DOI: 10.1186/s12879-024-09691-5.


C-Reactive Protein in Atherosclerosis-More than a Biomarker, but not Just a Culprit.

Kirkgoz K Rev Cardiovasc Med. 2024; 24(10):297.

PMID: 39077585 PMC: 11262456. DOI: 10.31083/j.rcm2410297.


An inflammation-based model for identifying severe acute pancreatitis: a single-center retrospective study.

Li X, Zhang Y, Wang W, Meng Y, Chen H, Chu G BMC Gastroenterol. 2024; 24(1):63.

PMID: 38317108 PMC: 10840143. DOI: 10.1186/s12876-024-03148-4.


Serum C-reactive protein greater than 75 mg/dL as an early available laboratory predictor of severe COVID-19: A systematic review.

Nazemi P, SeyedAlinaghi S, Azarnoush A, Mabadi A, Khaneshan A, Salehi M Immun Inflamm Dis. 2023; 11(12):e1130.

PMID: 38156391 PMC: 10753867. DOI: 10.1002/iid3.1130.